VALIANT LABORATORIES Financial Statement Analysis
|
||
The Revenues of VALIANT LABORATORIES have decreased by -45.48% YoY .
The Earnings Per Share (EPS) of VALIANT LABORATORIES has decreased by -99.21 % YoY. |
REVENUES |
OPERATING MARGIN |
PROFIT AFTER TAX |
EPS |
ROCE |
VALIANT LABORATORIES Last 5 Annual Financial Results
[BOM: 543998|NSE : VALIANTLAB]
Consolidated | Mar2024 | Mar2023 |
---|---|---|
Revenues | ₹182 Cr | ₹334 Cr |
Expenses | ₹190 Cr | ₹299 Cr |
Operating Profit (Excl OI) | ₹-8.41 Cr | ₹35 Cr |
Other Income | ₹9.68 Cr | ₹4.89 Cr |
Interest | ₹0.08 Cr | ₹0.25 Cr |
Depreciation | ₹1.97 Cr | ₹1.56 Cr |
Profit Before Tax | ₹-0.77 Cr | ₹38 Cr |
Profit After Tax | ₹0.32 Cr | ₹29 Cr |
Consolidated Net Profit | ₹0.32 Cr | ₹29 Cr |
Earnings Per Share (Rs) | ₹0.07 | ₹8.91 |
PAT Margin (%) | 0.18 | 8.68 |
ROE(%) | 0.19 | 28.86 |
ROCE(%) | -0.29 | 24.01 |
Total Debt/Equity(x) | 0.32 | 0.59 |
Key Financials |
||
Market Cap | : | ₹ 462.8 Cr |
Revenue (TTM) | : | ₹ 106.2 Cr |
Net Profit(TTM) | : | ₹ -4.1 Cr |
EPS (TTM) | : | ₹ -1.0 |
P/E (TTM) | : | - |
Industry Peers & Returns | 1W | 1M | 1Y |
VALIANT LABORATORIES | 8.2% | -2.5% | -44.8% |
SUN PHARMACEUTICAL INDUSTRIES | 0.6% | -2.1% | 16.5% |
CIPLA | 3.6% | 0.2% | 2.3% |
DR REDDYS LABORATORIES | 3% | -8.4% | 0% |
ZYDUS LIFESCIENCES | 3.2% | -1% | 27.4% |
DIVIS LABORATORIES | 4.3% | 6.5% | 63.9% |
MANKIND PHARMA | -2.5% | -8% | 16.5% |
TORRENT PHARMACEUTICALS | 2.9% | -0.5% | 19.4% |
LUPIN | 8.2% | 0.4% | 37% |
VALIANT LABORATORIES Revenues
[BOM: 543998|NSE : VALIANTLAB]
Y-o-Y | -45.48 % |
5 Yr CAGR | -45.48 % |
Years | Revenues | % Change | |
---|---|---|---|
Mar2024 | ₹182 Cr | -45.48 | |
Mar2023 | ₹334 Cr | - |
VALIANT LABORATORIES Operating Profit
[BOM: 543998|NSE : VALIANTLAB]
Y-o-Y | Negative |
5 Yr CAGR | Negative |
Years | Operating Profit | % Change | |
---|---|---|---|
Mar2024 | ₹-8.41 Cr | Negative | |
Mar2023 | ₹35 Cr | - |
Operating Margins | |
---|---|
Y-o-Y | Negative |
5 Yr CAGR | Negative |
Years | Operating Margin% | % Change | |
---|---|---|---|
Mar2024 | -4.62% | Negative | |
Mar2023 | 10.5% | - |
VALIANT LABORATORIES Profit After Tax
[BOM: 543998|NSE : VALIANTLAB]
Y-o-Y | -98.90 % |
5 Yr CAGR | -98.90 % |
Years | Profit After Tax | % Change | |
---|---|---|---|
Mar2024 | ₹0.32 Cr | -98.90 | |
Mar2023 | ₹29 Cr | - |
PAT Margins | |
---|---|
Y-o-Y | -97.93 % |
5 Yr CAGR | -97.93 % |
Years | PAT Margin(%) | % Change | |
---|---|---|---|
Mar2024 | 0.18 % | -97.93 | |
Mar2023 | 8.68 % | - |
VALIANT LABORATORIES Earnings Per Share (EPS)
[BOM: 543998|NSE : VALIANTLAB]
Y-o-Y | -99.21 % |
5 Yr CAGR | -99.21 % |
Years | EPS | % Change | |
---|---|---|---|
Mar2024 | ₹0.07 | -99.21 | |
Mar2023 | ₹8.91 | - |
VALIANT LABORATORIES Return on Capital Employed (ROCE)
[BOM: 543998|NSE : VALIANTLAB]
Y-o-Y | Negative |
5 Yr CAGR | Negative |
Years | ROCE | % Change | |
---|---|---|---|
Mar2024 | -0.29% | Negative | |
Mar2023 | 24.01% | - |
VALIANT LABORATORIES Share Price vs Sensex
Current Share Price | : | ₹106.4 |
Current MarketCap | : | ₹ 462.8 Cr |
Updated EOD on | : | Feb 07,2025 |
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
VALIANT LABORATORIES | 8.2% |
-2.5% |
-44.8% |
SENSEX | 0.5% |
0.3% |
7.9% |
VALIANT LABORATORIES related INDICES
You may also like the below Video Courses
FAQ about VALIANT LABORATORIES Financials
How the annual revenues of VALIANT LABORATORIES have changed ?
The Revenues of VALIANT LABORATORIES have decreased by -45.48% YoY .
How the Earnings per Share (EPS) of VALIANT LABORATORIES have changed?
The Earnings Per Share (EPS) of VALIANT LABORATORIES has decreased by -99.21 % YoY .
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs